Nimodipine is known to improve postisch emic cerebral blood flow (CBF) and neurologic outcome in experimental animals. Whether or not the two obser vations are related is unknown. This study searched for a possible improved rate of brain metabolic recovery in an imals treated with nimodipine postischemia. Complete cerebral ischemia was produced for 11 min in 16 dogs, followed by reperfusion for 70 min. Prior to ischemia, glucose was administered (0.75 g . kg-I) in 12 dogs. Half of the glucose-treated dogs were given i. v. nimodipine, beginning 5 min postischemia (10 I-lg . kg-I bolus fol lowed by 1 I-lg . kg-I. min -I). The other half were given only saline postischemia. The remaining four dogs were given no glucose and received saline only postischemia. In all dogs, serial brain biopsies were taken at 2, 20, 40, and 70 min postischemia. In 5 dogs, the integrity of the blood-brain barrier (BBB) was tested by injection of
It is well established that following a period of complete cerebral ischemia there is, upon reperfu sion, a brief period of hyperemia, followed by a prolonged period of decreased cerebral blood flow (CBF) (Steen et aI. , 1978) . The latter state has been called the delayed postischemic hypoperfusion state. It has been speculated that this low flow state contributes to the ultimate brain damage that may follow a period of complete ischemia. Nimodipine has been consistently shown to dramatically im prove the postischemic hypoperfusion state in a va riety of animal models (Steen et aI. , 1983 (Steen et aI. , , 1984 Milde et aI., 1986) . Nimodipine has also been re ported to improve neurologic functional outcome following complete cerebral ischemia in both dogs Evans blue dye and postmortem examination of the brains. Brain biopsies were assayed for concentrations of phosphocreatine, ATP, ADP, AMP, glucose, lactate, and pyruvate. In all dogs, there was rapid restoration of a normal brain energy state following reperfusion. Brain lactate had returned to near normal in all dogs by 70 min postischemia, and the rate of lactate depletion was not different between groups. The integrity of the BBB was only minimally affected. A portion of the brain lactate was converted to pyruvate rather than crossing the BBB. If lactate is a valid marker of the washout of metabolic products postischemia, there is no apparent benefit re sulting from a nimodipine-induced increase in CBF during the initial 70 min following ischemia. Key Words: Brain lactate-Calcium blockers-Cerebral blood flow -Cerebral ischemia-Cerebral metabolites-Nimodi pine. (Steen et aI. , 1983) and primates (Steen et aI. , 1985) . It is commonly assumed that the latter is re lated to the improved CBF.
As yet, there has been no convincing demonstra tion of a measurable beneficial effect of an im proved CBF that might explain the improved out come. The current study examined the possibility that an improved postischemic CBF might improve the rate of cerebral metabolic recovery. For this purpose, we focused on the rate of depletion of brain lactate following complete ischemia in the hopes that it would serve as a marker for the rate of washout of undesirable metabolic products that were produced during the ischemic period.
MATERIALS AND METHODS
Eighteen mongrel dogs weighing 12-18 kg and of either sex were studied. The protocol was approved by the in stitutional animal care committee and complied with all federal regulations. Anesthesia was induced with halo thane, followed by endotracheal intubation and me chan-ical ventilation with a Harvard pump. Anesthesia was maintained with 1 % halothane and 70% nitrous oxide in oxygen. A femoral vein and artery were cannulated for intravenous fluids, blood samples, drug administration, and monitoring mean arterial blood pressure (MABP). Muscle paralysis was induced and maintained with i.v. succinylcholine, 150 mg' h-I. A craniotomy was per formed in order to fully expose both cerebral hemi spheres with the dura intact. Two sets of electroencepha logram (EEG) leads were placed bilaterally for intermit tent recordings. Thereafter, a right thoracotomy in the fourth intercoastal space was completed in order to ex pose the heart and great vessels. Umbilical tapes were placed around the ascending aorta, the inferior vena cava, and the superior vena cava above the azygos vein. Body temperature was measured with an esophageal thermistor. The EEG and arterial pressure were dis played on an oscilloscope and intermittently recorded. Blood gases were measured on IL 1303 electrodes at 3rc. Hemoglobin was determined on an IL 282 CO-ox imeter. Blood glucose and lactate were measured by membrane-bound enzyme techniques on YI 23A ana lyzers. End-tidal halothane and CO2 concentrations were monitored with a mass spectrometer (Perkin-Elmer 1100).
When the surgery was completed, all wound edges were infiltrated with 1% procaine, and the halothane was discontinued. When end-expired halothane was <0.15% (after at least 20 min), control conditions were estab lished and documented. This required a Pao2 of 100-200 mm Hg, a Paco2 of 37-41 mm Hg, a buffer base of 40-45 meq . L -I, and an esophageal temperature of near 37°C. Upon achieving control conditions, complete cerebral ischemia was produced by simultaneously occluding the aorta and venae cavae. Completeness of ischemia was confirmed by immediate loss of the arterial pressure wave and by onset of an isoelectric EEG within 20-40 s. The nitrous oxide was then replaced with 100% oxygen. Ischemia was maintained for 11 min, during which time the dura was opened bilaterally. After 9 min of ischemia, all dogs received sodium bicarbonate (30-40 meq) and a 20-30-ml saline bolus. At 10 min and 45 s, the venae cavae tapes were released, and at 11 min, the aortic tape was released. Upon release of the tapes, the inspired gases were changed to 50% nitrogen and 50% oxygen. During the initial 2 min postischemia, vital signs were closely monitored until an MABP of >60 mm Hg was achieved (usually within the first minute). At 2 min postischemia, a brain biopsy was taken with a vacuum device that delivers a core of brain, 100-200 mg, into liquid nitrogen in less than 1 s (Kramer et aI., 1968) . In the first several minutes postischemia, the blood gases were adjusted by altering tidal volume, inspired oxygen concentration, and the administration of i.v. sodium bi carbonate, as needed. Thereafter, sequential biopsies were taken at 20, 40, and 70 min. In 5 dogs, after the final biopsy, 1% Evans blue dye, 3 ml . kg-I, was given intra venously. After 30 min, these dogs were killed with intra venous potassium, and the brains were removed for in spection. The other dogs were killed immediately after the 70-min biopsy. The brain biopsies were stored at -72°C for a maximum of 1 week, after which they were prepared for analysis in a refrigerated chamber at -25°C. The tissue extracts were analyzed with enzymatic fluoro metric methods for phosphocreatine (PCr), ATP, ADP, AMP, glucose, lactate, and pyruvate (Lowry and Passon- 1987 neau, 1972). The sum of the adenine nucleotides (Ad) was calculated as 2:(Ad) = (ATP) + (ADP) + (AMP). The energy state of the tissue was expressed as the energy charge (EC) of the adenine pool (Atkinson, 1968) :
There were three treatment groups to which the dogs were randomly assigned. Two groups were given a 15min intravenous infusion of 50% glucose to a total dose of 0.75 g . kg-I at least 30 min prior to inducing ischemia. At 5 min postischemia, one of the groups that was given glucose was then given a bolus of nimodipine, 10 jJ.g' kg-I i.v., followed by an infusion for 65 min of 1 jJ.g . kg-I. min -I. The other group given glucose re ceived a similar fluid volume i.v., but of saline only. A third group was not given glucose and also received i.v. saline only following ischemia.
Mean values were calculated and are reported with their standard errors and the number of observations. Statistical differences between groups at each time period or within groups between each time period were deter mined by an analysis of variance. If significance was achieved, individual comparisons were carried out using the Bonferroni correction of Student's t test. A p-value of <0.05 (corrected) was considered to be significant.
RESULTS
Two dogs were discarded from the study. In one dog, resuscitation of the heart was not possible. In another dog, the initial brain biopsy produced un controlled hemorrhage and herniation of the brain.
Among the physiologic variables measured only the expected differences were observed (Table 1) . Thus, following 11 min of complete whole body ischemia, there was a small decrease in esophageal temperature and a significant acidosis (despite bi carbonate therapy) with increased blood lactate. The significant increase in Paco2 may in part have been secondary to bicarbonate therapy as well as whole body ischemia. By 20 min postischemia, the acid-base balance was normal, whereas blood lac tate remained increased until 40 min postischemia. Withholding glucose in the control period resulted in a significantly lower control blood glucose in the saline group. Thereafter, differences between blood glucoses were not significant. In the nimodipine group, the expected decrease in MABP was ob served at every time interval after therapy was initi ated. In addition, a slower heart rate was observed at 40 and 70 min in this group.
The brain metabolites measured in the postisch emic period are tabulated in Ta ble 2. As expected, there was rapid restoration of the high-energy phosphates, with a normal energy charge at 2 min postischemia. The sum of the adenine nucleotides was decreased in all groups and was still less than normal at 70 min postischemia. By 20 min post- ischemia, the EC was above normal in all groups (Fig. 1) ; this was statistically significant for each of the groups and presumably reflects a simple over shoot. The EC returned to normal by 70 min post ischemia. Brain glucose was nearly depleted even after 2 min of reperfusion, whereas brain lactates were greatly increased. Numerically, the animals given glucose had higher mean brain lactates throughout the postischemic period, but none of the differences achieved significance. Thus, the rate of decline of brain lactate was similar in all groups (Fig. 2) , and by 70 min postischemia, brain lactates were near normal. Brain pyruvate concen-
tration was increased almost fivefold at 20 min post ischemia in all groups and then returned to near normal by 70 min postischemia (Fig. 3) . In sum mary, there were no significant differences in brain metabolites between the three groups at any of the measurement periods postischemia.
In the five dogs injected with Evans blue dye, there was a 1 + leakage of dye into brain tissue on a scale of 0 to 3 + (Rapoport et al. , 1977) . Three of these dogs were given saline only, and one was given nimodipine and glucose and the other saline and glucose. The postischemic brain metabolites in these dogs were representative of the entire group. a All concentration values are in JJ.. mol . g-l.
Laboratory normals: ATP, 2.01 ± 0. 01; PCr, 2.99 ± 0. 12; ADP, 0.38 ± 0.01; AM P, 0. 14 ± 0.00; glucose, 2.46 ± 0. 18; lactate, 1.23 ± 0.04; pyruvate, 0. 12 ± 0.00; LI P, 11 ± 0; and EC, 0.87 ± 0.00 (Roald et aI., 1986) . 
DISCUSSION
The purpose of this study was an attempt to identify a postischemic effect of nimodipine that might be interpreted as potentially beneficial and that could be attributed to an increased cerebral blood flow. No such effect was identified. There is no doubt that nimodipine administered in the doses used in this study will, in dogs, significantly in crease CBF in the postischemic period (Steen et al. , 1983 (Steen et al. , , 1984 . This effect of nimodipine is consi s tently demonstrable and is almost immediate; fur thermore, the effect is demonstrable even when ni modipine treatment is delayed for as long as 1 h postischemia (Milde et aI. , 1986) . The magnitude of the effect is such that CBF is increased 50-100% (Steen et aI. , 1978) from a pretreatment level of ap proximately 25 mI, 100 g-I . min-I. As nimodipine also improves neurologic functional outcome fol lowing complete ischemia (Steen et aI. , 1983 (Steen et aI. , , 1985 , it is reasonable to assume that the CBF effects ac count, at least in part, for the outcome effects.
However, it is yet to be demonstrated in what manner, if any, the improved CBF results in im proved outcome. Intuitively, it seems that an in creased delivery of substrate in the postischemic period should be beneficial compared to untreated animals that remain in a persistent postischemic hypoperfusion state. If this latter state results in a meaningful degree of cerebral hypoxia, then an in crease in oxygen delivery should result in a mea sureable increase in cerebral oxygen consumption (CMR02). In canine studies in which postischemic CMR02 was measured with and without nimodi pine treatment, Steen et aI. (1983) reported no in crease in CMR02 in one study and only a marginal increase in another study (Steen et aI., 1984) . In the latter study, nimodipine treatment was not different from treatment with the solvent for nimodipine alone and differed only from previously studied un treated dogs. Furthermore, if the reported differ ences had been compared as percentages of the control values, there would have been no statistical differences. Thus, it is far from certain whether or not increased oxygen delivery in the postischemic period does result in a meaningful increase in ox ygen consumption. Furthermore, it is well estab lished in this and other studies (Steen et al. , 1978) that within the first 2 h postischemia, cerebral lac tate concentrations return to normal from initially very high levels. As the postischemic hypoperfu sion state persists for at least 6 h in dogs (Steen et ai., 1978) , it is difficult to understand how, if this state is causing persistent cerebral hypoxia, cere bral lactate levels could decrease to normal at the same time; indeed, a further increase might be ex pected as brain glucose concentrations are replen ished.
Given these considerations, it seems entirely likely that there is no persistent post ischemic hyp oxic state; rather, O2 delivery may well be adequate for the existing needs. An alternative possible ben eficial effect from an increased postischemic CBF could be an increased washout of potentially toxic metabolic products resulting from the period of complete ischemia. We considered cerebral lactate to be a readily measurable metabolic product of the ischemic insult and expected that in the presence of a damaged blood-brain barrier, it could serve as a marker for the washout of undesirable metabolic products. In order to exaggerate any possible ef fects, we pretreated the majority of our dogs with glucose to increase postischemic brain lactate. If brain lactate is a valid marker, then the results of this study clearly fail to show that an improved postischemic CBF improves the rate of metabolic recovery of the brain. However, it is entirely possible that lactate is not a valid marker in this model for the washout rate of other metabolic products. Under normal condi tions, lactate crosses the blood-brain barrier by a facilitated mechanism in common with other short chain monocarboxylic acids (Rapoport, 1976) . This mechanism is, however, saturable, such that in the rat brain, influx saturates at 3-4 times normal plasma concentrations (Oldendorf, 1972) . If the same can be assumed for efflux in postischemic dogs, and if the blood-brain barrier is intact, then the rate of decline in lactate at concentrations ex ceeding 4-5 /-Lmol . g-l should be independent of CBF. In the five dogs we examined, the blood brain barrier at 70-100 min postischemia was not intact, but the leakage of Evans blue dye was cer tainly not striking. Thus, it seems likely that the rate of lactate depletion in our dogs would not be a simple function of CBF. Rather, it appears that a major mechanism whereby brain lactate depletes is by conversion to pyruvate and subsequent mito chondrial oxidation. Thus, in our dogs, at 20 min postischemia, at a time when lactate was rapidly decreasing, there was a fivefold increase above normal in pyruvate concentrations. By 70 min post ischemia, pyruvate concentrations had returned to near normal in concert with the lactate concentra tions. Similar observations (of lesser magnitude) have been previously reported in rats and were sim ilarly interpreted (Ljunggren et al., 1974) .
This study does not rule out the possibility that nimodipine prevents a delayed secondary energy failure at some time beyond 70 min postischemia; clearly, no such failure occurred during the study time selected. Neither does the restoration of a normal energy state in relatively large (100-200 mg) cortical samples necessarily relate to the oc currence of selective neuronal necrosis in noncor tical tissues or in small populations of cortical neu rons. In the event of the latter, a nimodipine-in duced increase in regional CBF might be beneficial without being reflected by global cortical measure ments.
Given the above considerations, the negative re sults of this study permit only limited interpretation and do not disprove the possibility that an im proved postischemic CBF improves the rate of brain metabolic recovery. Perhaps a different ap proach would yield a different answer. Still, in con sidering the fact that prior to the onset of the de layed postischemic hypoperfusion state there is a characteristic brief (10-20 min) but striking hyper emic state (Steen et al. , 1978) , one might expect that any undesirable metabolic products that are not limited by the blood-brain barrier would likely be rapidly depleted during that time.
Finally, it should be noted that Sakabe et ai. (1986) recently reported that another calcium entry blocker, nicardipine, in canine models identical to the ones used by us also improved postischemic CBF but did not improve outcome. Given those re sults and a failure to demonstrate any convincing favorable effects resulting from an increase in post ischemic CBF, it seems increasingly likely that the beneficial effects of nimodipine on outcome are unrelated to the CBF effect.
